The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Open accessAbstract
Various physiological processes involve appropriate tissue developmental process and homeostasis - the pathogenesis of several diseases connected with deregulatory apoptosis process. Apoptosis plays a crucial role in maintaining a balance between cell death and division, evasion of apoptosis results in the uncontrolled multiplication of cells leading to different diseases such as cancer. Currently, the development of apoptosis targeting anticancer drugs has gained much interest since cell death induced by apoptosis causes minimal inflammation. The understanding of complexities of apoptosis mechanism and how apoptosis is evolved by tumor cells to oppose cell death has focused research into the new strategies designed to induce apoptosis in cancer cells. This review focused on the underlying mechanism of apoptosis and the dysregulation of apoptosis modulators involved in the extrinsic and intrinsic apoptotic pathway, which include death receptors (DRs) proteins, cellular FLICE inhibitory proteins (c-FLIP), anti-apoptotic Bcl-2 proteins, inhibitors of apoptosis proteins (IAPs), tumor suppressor (p53) in cancer cells along with various current clinical approaches aimed to selectively induce apoptosis in cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedSung, B., Park, B., Yadav, V. R., & Aggarwal, B. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090209 · Cited by 123
RetractedApoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Autophagy: process and function
Mizushima, N. (2007) · Genes & Development · doi:10.1101/gad.1599207 · Cited by 3,967
Autophagy: cellular and molecular mechanisms
Glick, D., Barth, S., & Macleod, K. F. (2010) · The Journal of Pathology · doi:10.1002/path.2697 · Cited by 3,802
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
X-linked IAP is a direct inhibitor of cell-death proteases
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., & Reed, J. C. (1997) · Nature · doi:10.1038/40901 · Cited by 1,955
Programmed Cell Death in Animal Development and Disease
Fuchs, Y., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.10.033 · Cited by 1,915
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
Ouyang, L., Shi, Z., Zhao, S., Wang, F. ‐., Zhou, T. ‐., Liu, B., & Bao, J. ‐. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00845.x · Cited by 1,452
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
Crosstalk between apoptosis.; necrosis and autophagy
Nikoletopoulou, V., Markaki, M., Palikaras, K., & Tavernarakis, N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.001 · Cited by 1,366
Death by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,364
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254
FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
Medema, J. P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2794 · Cited by 1,188
Croce, C. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072367 · Cited by 1,055
Histone deacetylases and cancer
Glozak, M. A., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210610 · Cited by 1,031
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Kang, M. H., & Reynolds, C. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0144 · Cited by 1,016
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 897
Wilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70261-8 · Cited by 876
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
Cell death modalities: classification and pathophysiological implications
Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402148 · Cited by 832
Roberts, A. W., Seymour, J. F., Brown, J. R., Wierda, W. G., Kipps, T. J., Khaw, S. L., Carney, D. A., He, S. Z., Huang, D. C. S., Xiong, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7898 · Cited by 830
Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors
Issaeva, N., Bozko, P., Enge, M., Protopopova, M., Verhoef, L. G. G. C., Masucci, M., Pramanik, A., & Selivanova, G. (2004) · Nature Medicine · doi:10.1038/nm1146 · Cited by 750
Apoptosis and cancer: mutations within caspase genes
Ghavami, S., Hashemi, M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., Bus, C. J., Kadkhoda, K., Wiechec, E., Halayko, A. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066944 · Cited by 713
Life and death by death receptors
Guicciardi, M. E., & Gores, G. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-111005 · Cited by 690
A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
Li, L., Thomas, R. M., Suzuki, H., De Brabander, J. K., Wang, X., & Harran, P. G. (2004) · Science · doi:10.1126/science.1098231 · Cited by 656
Role of p53 in Cell Death and Human Cancers
Ozaki, T., & Nakagawara, A. (2011) · Cancers · doi:10.3390/cancers3010994 · Cited by 650
Cell death in the nervous system
Bredesen, D. E., Rao, R. V., & Mehlen, P. (2006) · Nature · doi:10.1038/nature05293 · Cited by 636
Vaseva, A. V., & Moll, U. M. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.10.005 · Cited by 618
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis
Los, M., Craen, M. V. D., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W., & Schulze-Osthoff, K. (1995) · Nature · doi:10.1038/375081a0 · Cited by 607
Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment
Goldar, S., Khaniani, M. S., Derakhshan, S. M., & Baradaran, B. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.6.2129 · Cited by 606
Bedikian, A. Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A. C., DeConti, R., Hersh, E. M., Hersey, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0483 · Cited by 600
A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
Llambi, F., Moldoveanu, T., Tait, S. W. G., Bouchier-Hayes, L., Temirov, J., McCormick, L. L., Dillon, C. P., & Green, D. R. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.001 · Cited by 596
Fernald, K., & Kurokawa, M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.006 · Cited by 579
Autophagy and apoptosis: where do they meet?
Mukhopadhyay, S., Panda, P. K., Sinha, N., Das, D. N., & Bhutia, S. K. (2014) · Apoptosis · doi:10.1007/s10495-014-0967-2 · Cited by 572
Necroptosis: A Specialized Pathway of Programmed Necrosis
Galluzzi, L., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2008.12.004 · Cited by 561
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., et al. (2001) · Nature Medicine · doi:10.1038/91000 · Cited by 543
Chinnaiyan, A. M., Prasad, U., Shankar, S., Hamstra, D. A., Shanaiah, M., Chenevert, T. L., Ross, B. D., & Rehemtulla, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030545097 · Cited by 530
History of Cancer, Ancient and Modern Treatment Methods
Sudhakar, A. (2009) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.100000e2 · Cited by 504
Structural Basis of Caspase Inhibition by XIAP
Huang, Y., Park, Y. C., Rich, R. L., Segal, D., Myszka, D. G., & Wu, H. (2001) · Cell · doi:10.1016/s0092-8674(01)00273-2 · Cited by 467
Getting TRAIL back on track for cancer therapy
Lemke, J., von Karstedt, S., Zinngrebe, J., & Walczak, H. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.81 · Cited by 457
Antonia, S. J., Mirza, N., Fricke, I., Chiappori, A., Thompson, P., Williams, N., Bepler, G., Simon, G., Janssen, W., Lee, J.-H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2013 · Cited by 444
Cell Death Mechanisms and Their Implications in Toxicology
Orrenius, S., Nicotera, P., & Zhivotovsky, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq268 · Cited by 411
The Pathways of Cell Death: Oncosis, Apoptosis, and Necrosis
Trump, B. E., Berezesky, I. K., Chang, S. H., & Phelps, P. C. (1997) · Toxicologic Pathology · doi:10.1177/019262339702500116 · Cited by 410
Apoptosis in the development and treatment of cancer
Gerl, R. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh283 · Cited by 385
Regulation of CD95/Fas signaling at the DISC
Lavrik, I. N., & Krammer, P. H. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.155 · Cited by 355
Apoptotic cell signaling in cancer progression and therapy
Plati, J., Bucur, O., & Khosravi-Far, R. (2011) · Integrative Biology · doi:10.1039/c0ib00144a · Cited by 319
Recent advances in understanding the cell death pathways activated by anticancer therapy
Kim, R. (2005) · Cancer · doi:10.1002/cncr.20947 · Cited by 314
Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
Yue, X., Zhao, Y., Xu, Y., Zheng, M., Feng, Z., & Hu, W. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.030 · Cited by 308
Ca2+ Signaling, Mitochondria and Cell Death
Pinton, P., Romagnoli, A., Rizzuto, R., & Giorgi, C. (2008) · Current Molecular Medicine · doi:10.2174/156652408783769571 · Cited by 305
Apoptosome Structure, Assembly, and Procaspase Activation
Yuan, S., & Akey, C. W. (2013) · Structure · doi:10.1016/j.str.2013.02.024 · Cited by 281
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
Baig, S., Seevasant, I., Mohamad, J., Mukheem, A., Huri, H. Z., & Kamarul, T. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.275 · Cited by 279
Targeting the Bcl-2 family for cancer therapy
Thomas, S., Quinn, B. A., Das, S. K., Dash, R., Emdad, L., Dasgupta, S., Wang, X.-Y., Dent, P., Reed, J. C., Pellecchia, M., et al. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.733001 · Cited by 277
Dimberg, L. Y., Anderson, C. K., Camidge, R., Behbakht, K., Thorburn, A., & Ford, H. L. (2013) · Oncogene · doi:10.1038/onc.2012.164 · Cited by 276
c-FLIP, a master anti-apoptotic regulator.
Safa, A. R. (2012) · PubMed · Cited by 272
Arnt, C. R., Chiorean, M. V., Heldebrant, M. P., Gores, G. J., & Kaufmann, S. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207578200 · Cited by 263
Younes, A., Sureda, A., Ben-Yehuda, D., Zinzani, P. L., Ong, T.-C., Prince, H. M., Harrison, S. J., Kirschbaum, M., Johnston, P., Gallagher, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.1350 · Cited by 263
Programmed Cell Death in Parkinson's Disease
Venderova, K., & Park, D. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009365 · Cited by 247
Soria, J.-C., Márk, Z., Zatloukal, P., Szima, B., Albert, I., Juhász, E., Pujol, J.-L., Kozielski, J., Baker, N., Smethurst, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2623 · Cited by 246
Kojima, K., Konopleva, M., McQueen, T., O'Brien, S., Plunkett, W., & Andreeff, M. (2006) · Blood · doi:10.1182/blood-2005-12-5148 · Cited by 245
Targeting the extrinsic apoptosis signaling pathway for cancer therapy
Sayers, T. J. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1008-4 · Cited by 241
Yang, L., Mashima, T., Sato, S., Mochizuki, M., Sakamoto, H., Yamori, T., Oh‐hara, T., & Tsuruo, T. (2003) · PubMed · Cited by 238
Najafov, A., Chen, H., & Yuan, J. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.03.002 · Cited by 223
Human IAP-Like Protein Regulates Programmed Cell Death Downstream of Bcl-x L and Cytochrome c
Duckett, C. S., Li, F., Wang, Y., Tomaselli, K. J., Thompson, C. B., & Armstrong, R. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.608 · Cited by 217
Naseri, M. H., Mahdavi, M., Davoodi, J., Tackallou, S. H., Goudarzvand, M., & Neishabouri, S. H. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0204-2 · Cited by 202
Hotte, S. J., Hirte, H. W., Chen, E. X., Siu, L. L., Le, L. H., Corey, A., Iacobucci, A., MacLean, M., Lo, L., Fox, N. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1416 · Cited by 190
The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteins
Mérino, D., Giam, M., Hughes, P. D., Siggs, O. M., Heger, K., O'Reilly, L. A., Adams, J. M., Strasser, A., Lee, E. F., Fairlie, W. D., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200905153 · Cited by 185
Speetjens, F. M., Kuppen, P. J. K., Welters, M. J. P., Essahsah, F., Voet van den Brink, A. M. E. G., Lantrua, M. G. K., Valentijn, A. R. P. M., Oostendorp, J., Fathers, L. M., Nijman, H. W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2227 · Cited by 185
Evolution of apoptosis-like programmed cell death in unicellular protozoan parasites
Kaczanowski, S., Sajid, M., & Reece, S. E. (2011) · Parasites & Vectors · doi:10.1186/1756-3305-4-44 · Cited by 184
Liu, G., Kelly, W. K., Wilding, G., Leopold, L., Brill, K., & Somer, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2985 · Cited by 181
Trarbach, T., Moehler, M., Heinemann, V, Köhne, C.-H., Przyborek, M., Schulz, C., Sneller, V, Gallant, G., & Kanzler, S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605507 · Cited by 180
Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F., & Soddu, S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.008 · Cited by 174
FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP
Tsuchiya, Y., Nakabayashi, O., & Nakano, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226232 · Cited by 172
Bagnoli, M., Canevari, S., & Mezzanzanica, D. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.015 · Cited by 170
Greco, F. A., Bonomi, P., Crawford, J., Kelly, K., Oh, Y., Halpern, W., Lo, L., Gallant, G., & Klein, J. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.12.011 · Cited by 168
Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy
Safa, A. R., & Pollok, K. E. (2011) · Cancers · doi:10.3390/cancers3021639 · Cited by 167
Kelly, R. J., Thomas, A., Rajan, A., Chun, G., Lopez-Chavez, A., Szabo, E., Spencer, S., Carter, C. A., Guha, U., Khozin, S., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt249 · Cited by 166
Tolcher, A. W., Chi, K., Kuhn, J., Gleave, M., Patnaik, A., Takimoto, C., Schwartz, G., Thompson, I., Berg, K., D'Aloisio, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2145 · Cited by 166
Cancer therapeutics: Targeting the apoptotic pathway
Khan, K. H., Blanco-Codesido, M., & Molife, L. R. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.12.012 · Cited by 164
Liu, X., Yue, P., Chen, S., Hu, L., Lonial, S., Khuri, F. R., & Sun, S.-Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4274 · Cited by 162
Ghavami, S., Kerkhoff, C., Los, M., Hashemi, M., Sorg, C., & Karami-Tehrani, F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0903435 · Cited by 159
Wakelee, H. A., Patnaik, A., Sikic, B. I., Mita, M. M., Fox, N. L., Miceli, R. C., Ullrich, S. J., Fisher, G. A., & Tolcher, A. W. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp292 · Cited by 157
Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy
Safa, A. R. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s6-003 · Cited by 154
Targeting caspases in cancer therapeutics
Hensley, P. J., Mishra, M., & Kyprianou, N. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0128 · Cited by 150
Cohen, N. A., Stewart, M. L., Gavathiotis, E., Tepper, J. L., Bruekner, S. R., Koss, B. S., Opferman, J. T., & Walensky, L. D. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.018 · Cited by 148
A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors
Herbst, R. S., Kurzrock, R., Hong, D. S., Valdivieso, M., Hsu, C., Goyal, L., Juan, G., Hwang, Y. C., Wong, S., Hill, J. S., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0631 · Cited by 144
Death and more: DNA damage response pathways in the nematode C. elegans
Stergiou, L., & Hengartner, M. O. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401340 · Cited by 143
Proteolytic mechanisms in necrotic cell death and neurodegeneration
Artal‐Sanz, M., & Tavernarakis, N. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.052 · Cited by 142
Tumor suppressor p53 and its gain-of-function mutants in cancer
Liu, J., Zhang, C., & Feng, Z. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt144 · Cited by 136
Apoptosis in Cancer - An Update
Sankari, S., Masthan, K. M. K., Babu, N. A., Bhattacharjee, T., & Elumalai, M. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.10.4873 · Cited by 132
Histone deacetylase inhibitors and genomic instability
Éot-Houllier, G., Fulcrand, G., Magnaghi-Jaulin, L., & Jaulin, C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.06.005 · Cited by 127
Wang, W., Takimoto, R., Rastinejad, F., & El-Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2171-2181.2003 · Cited by 126
Schimmer, A. D., Estey, E. H., Borthakur, G. M., Carter, B. Z., Schiller, G. J., Tallman, M. S., Altman, J. K., Karp, J. E., Kassis, J., Hedley, D. W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8172 · Cited by 124
Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL
Belka, C., Schmid, B., Marini, P., Durand, E., Rudner, J., Faltin, H., BAMBERG, M., Schulze‐Osthoff, K., & Budach, W. (2001) · Oncogene · doi:10.1038/sj.onc.1204318 · Cited by 124
Modulation of death receptors by cancer therapeutic agents
Elrod, H. A., & Sun, S. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.2.5335 · Cited by 116
Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function
Wright, C. W., & Duckett, C. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26251 · Cited by 115
Svane, I. M., Pedersen, A. E., Johnsen, H. E., Nielsen, D. L., Kamby, C., Gaarsdal, E., Nikolajsen, K., Buus, S., & Claësson, M. H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0493-5 · Cited by 114
Rödel, F., Frey, B., Leitmann, W., Capalbo, G., Weiß, C., & Rödel, C. M. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.011 · Cited by 108
Fulda, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0227 · Cited by 107
Kojima, K., Konopleva, M. Y., Samudio, I. J., Schober, W. D., Bornmann, W. G., & Andreeff, M. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3520 · Cited by 101
Paik, P. K., Rudin, C. M., Pietanza, M. C., Brown, A. B., Rizvi, N. A., Takebe, N., Travis, W. D., James, L. P., Ginsberg, M. S., Juergens, R. A., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.05.005 · Cited by 100
An introduction to death receptors in apoptosis
Kumar, R., Herbert, P. E., & Warrens, A. Ν. (2005) · International Journal of Surgery · doi:10.1016/j.ijsu.2005.05.002 · Cited by 100
Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer
Dineen, S. P., Roland, C. L., Greer, R. M., Carbon, J. G., Toombs, J. E., Gupta, P. K., Bardeesy, N. M., Sun, H., Williams, N. S., Minna, J. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3892 · Cited by 98
Necrosis Is an Active and Controlled Form of Programmed Cell Death
Proskuryakov, S. Y., Gabai, V. L., & Konoplyannikov, A. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1015289521275 · Cited by 95
Progress and Prospects: Gene Therapy Clinical Trials (Part 2)
Uta Griesenbach, D. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303033 · Cited by 95
Wagner, L., Marschall, V., Karl, S., Cristofanon, S., Zobel, K., Deshayes, K., Vucic, D., Debatin, K., & Fulda, S. (2012) · Oncogene · doi:10.1038/onc.2012.108 · Cited by 92
Cancer gene therapy targeting cellular apoptosis machinery
Jia, L., Chen, S., & Yang, A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.008 · Cited by 84
Natural cellular inhibitors of caspases
LeBlanc, A. C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00017-4 · Cited by 83
Structural insights into the transcription-independent apoptotic pathway of p53
Chi, S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.3.261 · Cited by 83
Shankar, S., Singh, T. R., Fandy, T. E., Luetrakul, T., Ross, D. D., & Srivastava, R. K. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.16.6.1125 · Cited by 78
Banerji, U., van Doorn, L., Papadatos-Pastos, D., Kristeleit, R. S., Debnam, P. M., Tall, M., Stewart, A., Raynaud, F. I., Garrett, M. D., Toal, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3165 · Cited by 77
Dai, Y., Liu, M., Tang, W., Li, Y., Lian, J., Lawrence, T. S., & Xu, L. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-392 · Cited by 72
Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent
Burek, M., Maddika, S., Burek, M., Daniel, P. T., Schulze‐Osthoff, K., & Łoś, M. (2005) · Oncogene · doi:10.1038/sj.onc.1209258 · Cited by 70
Hu, Q., Wu, D., Chen, W., Zhen, Y., & Shi, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441568 · Cited by 64
Histone deacetylase inhibitors in cancer therapy. A review
Hraběta, J., Stiborová, M., Adam, V., Kizek, R., & Eckschlager, T. (2013) · Biomedical Papers · doi:10.5507/bp.2013.085 · Cited by 64
Carter, B. Z., Mak, D. H. F., Morris, S. J., Borthakur, G. M., Estey, E. H., Byrd, A. L., Konopleva, M. Y., Kantarjian, H. M., & Andreeff, M. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0545-1 · Cited by 62
FLIP as an Anti-Cancer Therapeutic Target
Yang, J. K. (2008) · Yonsei Medical Journal · doi:10.3349/ymj.2008.49.1.19 · Cited by 60
Becher, I., Dittmann, A., Savitski, M. M., Hopf, C., Drewes, G., & Bantscheff, M. (2014) · ACS Chemical Biology · doi:10.1021/cb500235n · Cited by 60
Shankar, S., Davis, R. B., Singh, K. P., Kurzrock, R., Ross, D. D., & Srivastava, R. K. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1004 · Cited by 59
Dai, Y., Liu, M., Tang, W., DeSano, J. T., Burstein, E., Davis, M. A., Pienta, K. J., Lawrence, T. S., & Xu, L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0188 · Cited by 59
The viral death effector Apoptin reveals tumor-specific processes
Rohn, J. L., & Noteborn, M. H. M. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000025808.48885.9c · Cited by 56
Pulling the plug on a cancer cell by eliminating XIAP with AEG35156
LaCasse, E. C. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.015 · Cited by 54
Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins
Finlay, D., Teriete, P., Vamos, M., Cosford, N. D. P., & Vuori, K. (2017) · F1000Research · doi:10.12688/f1000research.10625.1 · Cited by 51
Rinaldo, C., Prodosmo, A., Siepi, F., Moncada, A., Sacchi, A., Selivanova, G., & Soddu, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0337 · Cited by 50
LoRusso, P. M., Hong, D. S., Heath, E. I., Kurzrock, R., Wang, D., Hsu, M. L., Goyal, L., Wiezorek, J. S., Storgard, C. M., & Herbst, R. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3534 · Cited by 50
BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death
Wade, M., Rodewald, L. W., Espinosa, J. M., & Wahl, G. M. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6072 · Cited by 48
Ma, J., Chen, B., & Xin, X. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.06.011 · Cited by 48
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy
Azmi, A. S., Philip, P. A., Beck, F. W., Wang, Z., Banerjee, S., Wang, S., Yang, D., Sarkar, F. H., & Mohammad, R. M. (2010) · Oncogene · doi:10.1038/onc.2010.403 · Cited by 48
Camidge, D. R. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1167 · Cited by 48
Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?
Brinkmann, K., & Kashkar, H. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.61 · Cited by 47
A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors
Fukutomi, A., Hatake, K., Matsui, K., Sakajiri, S., Hirashima, T., Tanii, H., Kobayashi, K., & Yamamoto, N. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9666-9 · Cited by 46
Mahadevan, D., Chalasani, P., Rensvold, D., Kurtin, S., Pretzinger, C., Jolivet, J., Ramanathan, R. K., Hoff, D. D. V., & Weiss, G. J. (2012) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182467a13 · Cited by 43
Berenson, J. R., Hilger, J. D., Yellin, O., Boccia, R. V., Matous, J., Dressler, K. P., Ghazal, H. H., Jamshed, S., Kingsley, E. C., Harb, W. A., et al. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1910-2 · Cited by 36
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy
Wissink, E. H. J., Verbrugge, I., Vink, S. R., Schader, M. B., Schaefer, U., Walczak, H., Borst, J. G., & Verheij, M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.030 · Cited by 35
Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors
Ieranò, C., Chakraborty, A. R., Nicolae, A., Bahr, J. C., Zhan, Z., Pittaluga, S., Bates, S. E., & Robey, R. W. (2013) · Cell Cycle · doi:10.4161/cc.25914 · Cited by 33
Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells
Dai, D.-J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i2.193 · Cited by 31
The Opposing Roles of Cellular Inhibitor of Apoptosis Proteins in Cancer
Lau, R., & Pratt, M. A. C. (2012) · ISRN Oncology · doi:10.5402/2012/928120 · Cited by 29
Onyeagucha, B. C., Subbarayalu, P., Abdelfattah, N., Rajamanickam, S., Timilsina, S., Guzman, R. M., Zeballos, C. R., Eedunuri, V. K., Bansal, S., Mohammad, T. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20841 · Cited by 29
The Pathology of Tumors, Part III: Grading, Staging & Classification
Rosaí, J., & Ackerman, L. V. (1979) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.29.2.66 · Cited by 25
Pacey, S., Plummer, R., Attard, G., Bale, C., Calvert, H., Blagden, S. P., Fox, N. L., Corey, A. E., & Bono, J. S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3055 · Cited by 23
Programmed cell death takes flight: genetic and genomic approaches to gene discovery inDrosophila
Gorski, S. M., & Marra, M. A. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00114.2001 · Cited by 15
Neuman, M. G., Katz, G. G., Malkiewicz, I. M., Mathurin, P., Tsukamoto, H., Adachi, M., Ishii, H., Colell, A., García‐Ruiz, C., Fernández-Checa, J. C., et al. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00243-4 · Cited by 14
Apoptosis: Molecular Mechanisms
Cairrão, F., & Domingos, P. M. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0001150.pub2 · Cited by 12
Zhuang, J., Laing, N. M., Oates, M., Lin, K., Johnson, G. G., & Pettitt, A. R. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.81 · Cited by 12
Nardinocchi, L., Puca, R., Givol, D., & D’Orazi, G. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.09.018 · Cited by 12
Vaux, D. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_6 · Cited by 4
Cited by
Flavonoids as Anticancer Agents
Kopustinskiene, D. M., Jakstas, V., Savickas, A., & Bernatoniene, J. (2020) · Nutrients · doi:10.3390/nu12020457 · Cited by 1,295
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., & Mashele, S. (2022) · Molecules · doi:10.3390/molecules27175730 · Cited by 904
The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer
Jiang, M., Qi, L., Li, L., & Li, Y. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00349-0 · Cited by 686
Mustafa, M., Ahmad, R., Tantry, I. Q., Ahmad, W., Siddiqui, S., Alam, M., Abbas, K., Moinuddin, Hassan, M. I., Habib, S., et al. (2024) · Cells · doi:10.3390/cells13221838 · Cited by 595
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
KONTOMANOLIS, E. N., KOUTRAS, A., SYLLAIOS, A., SCHIZAS, D., MASTORAKI, A., GARMPIS, N., DIAKOSAVVAS, M., ANGELOU, K., TSATSARIS, G., PAGKALOS, A., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14622 · Cited by 389
Metadata
- Authors
- Jan, R., & Chaudhry, G.-E.-S.
- Venue
- Advanced Pharmaceutical Bulletin
- Publisher
- Maad Rayan Publishing Company
- Published
- 2019-06-01
- Volume
- 9
- Issue
- 2
- Pages
- 205-218
- ISSN
- 2228-5881 (ISSN-L)
- 2251-7308
- OpenAlex
- W2948680670
- Cited by
- 899
- References
- 155
- FWCI
- 22.42
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.